Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Case-Based Guide to Clinical EndocrinologyInitial Diagnosis and Management of Type 2 Diabetes Mellitus

A Case-Based Guide to Clinical Endocrinology: Initial Diagnosis and Management of Type 2 Diabetes... [Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Case-Based Guide to Clinical EndocrinologyInitial Diagnosis and Management of Type 2 Diabetes Mellitus

Editors: Davies, Terry F.
Suda, Nisha; Lee, Hanna J.
A Case-Based Guide to Clinical Endocrinology — Jan 4, 2022
Download PDF
14 pages

Loading next page...
 
/lp/springer-journals/a-case-based-guide-to-clinical-endocrinology-initial-diagnosis-and-Vfz67pDChr

References (25)

Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
ISBN
978-3-030-84366-3
Pages
353 –367
DOI
10.1007/978-3-030-84367-0_39
Publisher site
See Chapter on Publisher Site

Abstract

[Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.]

Published: Jan 4, 2022

Keywords: Type 2 diabetes (T2DM); Screening; Lifestyle modification; Time in range (TIR); Glycemic targets; Macrovascular complications; Microvascular complications

There are no references for this article.